HELENA MUIRRAGUI: Open Payments
NPI 1366451304 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 60 payments from 11 companies in 2025. Trend: 2023 $1,598 · 2024 $1,049 · 2025 $1,478
Food & beverage: $1,366Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $300 |
| Alkermes, Inc. | 12 | $224 |
| Lundbeck LLC | 8 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $186 |
| Otsuka America Pharmaceutical, Inc. | 7 | $161 |
| E.R. Squibb & Sons, L.L.C. | 3 | $90 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Bausch Health US, LLC | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $44 |
Products named: REXULTI, UZEDY, TRINTELLIX, LYBALVI, COBENFY, ARISTADA, INGREZZA, CAPLYTA.
Industry payments across IL — which companies pay providers there.
